tiprankstipranks
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
BEAM
Beam Therapeutics
RESEARCH TOOLSreports
Want to see BEAM full AI Analyst Report?

Beam Therapeutics (BEAM) Income Statement

2,215 Followers

Beam Therapeutics Income Statement

Last quarter (Q4 2025), Beam Therapeutics's total revenue was $114.11M, an increase of 279.52% from the same quarter last year. In Q4, Beam Therapeutics's net income was $244.30M. See Beam Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 139.74M$ 63.52M$ 377.71M$ 60.92M$ 51.84M
Gross Profit
$ 117.45M$ -304.04M$ 377.71M$ -250.67M$ -180.29M
Operating Expenses
$ 501.14M$ 111.53M$ 554.19M$ 87.81M$ 212.18M
Depreciation and Amortization
$ 6.34M$ 21.93M$ 29.53M$ 14.15M$ 7.45M
EBITDA
$ -29.92M$ -393.64M$ -146.95M$ -324.33M$ -230.06M
Operating Income
$ -383.69M$ -415.57M$ -176.49M$ -338.48M$ -392.46M
Other Income/Expenses
$ 303.70M$ 38.87M$ 45.32M$ 52.80M$ 21.83M
Pretax Income
$ -79.99M$ -376.70M$ -131.16M$ -285.68M$ -370.64M
Net Income
$ -79.99M$ -376.74M$ -132.53M$ -289.09M$ -370.64M
Per Share Metrics
Basic EPS
$ -0.81$ -4.58$ -1.72$ -4.13$ -5.77
Diluted EPS
$ -0.81$ -4.58$ -1.72$ -4.13$ -5.77
Weighted Average Shares Outstanding
 98.91M 82.31M 77.15M 70.02M 64.23M
Weighted Average Shares Outstanding (Diluted)
 98.91M 82.31M 77.15M 70.02M 64.23M
Currency in USD

Beam Therapeutics Earnings and Revenue History